News and Events

Over 90,400 New Zealanders estimated to be diagnosed with at least one in situ or invasive keratinocytic cancer in 2018

6 April 2018

This report estimates the numbers of diagnoses and the incidence rate of Non-Melanoma Skin (Keratinocytic) Cancer in New Zealand based on data extracted from a regional collection of pathology records of skin biopsies taken in 2009 to 2013. One of the key findings was that over 90,400 people will be diagnosed with at least one in situ or invasive Keratinocytic Cancer in 2018.  

Behavioural interventions have no clear effect on melanoma outcomes

25 March 2018

Behavioural interventions can improve sun protection behaviours in some cases, but there is inconsistent evidence that interventions are associated with a reduction in sunburn frequency or on skin cancer outcomes, according to this literature review. 

Immunotherapy shown to produce durable remissions

25 March 2018

A 60-year-old female with metastatic malignant melanoma of the scalp responding to ipilimumab adds to the evidence supporting early referral and initiation of ipilimumab in patients who can tolerate it, with the goal of producing a sustained treatment-free response and preserved quality of life, according to this recent case study.